Shenzhen, China · Founded 2021 · Privately Held (backing)
Developer of cardiovascular interventional imaging and treatment technologies designed to better treat patients. Cardioacc is based in Shenzhen, China and was founded in 2021. It has raised $14 million.
Last price · $/share
—
Implied valuation
—
Total raised
$14.0M
Last round
—
Team — not yet on record
No current team members for Cardioacc are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Cardioacc with a free account
·Watch Cardioacc: the Monday email on marks, rounds and moves
